Also
* Isis Pharmaceuticals Inc., a Carlsbad drug developer whose experimental cancer medication failed in a study, said partner Eli Lilly & Co. waived repayment of the $21-million loan used to build the manufacturing facility for the drug.
* Isis Pharmaceuticals Inc., a Carlsbad drug developer whose experimental cancer medication failed in a study, said partner Eli Lilly & Co. waived repayment of the $21-million loan used to build the manufacturing facility for the drug.
